N3 alkylated benzimidazole derivatives as MEK inhibitors
申请人:——
公开号:US20030232869A1
公开(公告)日:2003-12-18
Disclosed are compounds of the formula I
1
and pharmaceutically acceptable salts and prodrugs thereof, wherein W, R
1
, R
2
, R
7
, R
8
, R
9
and R
10
are as defined in the specification.
Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals. Also disclosed is a method of using such compounds in the treatment of hyperproliferative diseases in mammals, and pharmaceutical compositions containing such compounds.